Researchers have identified a backup mechanism of protein quality control which prevents the toxic effects of protein aggregation in specific tissues when normal methods of molecular monitoring fail.

The one-stage method was carried out on several hundred subjects to find the limits of variation in nonhypoprothrombinemic states. As representative samples, the results on 12 normal subjects studied ...